Title of Collaborative Activity:
(Former) HHS Behavioral Health Coordinating Committee (BHCC) Subcommittee on Opioids and Controlled Substances
Description of Collaborative Activity:
The National Institute of Drug Abuse (NIDA) Serves as Co-Chair with the Food and Drug Administration (FDA) on this inter-agency subcommittee addressing prescription drug abuse.
Type of Collaborative Activity:
Committee, Advisory Group, or Work Group
Year the Collaborative Activity Originated:
2009
NIH Participating Institutes/Centers/Office of the Director:
NIDA
HHS Agency Collaborators on this Activity:
AHRQ, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
